1029 related articles for article (PubMed ID: 19858078)
1. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
[TBL] [Abstract][Full Text] [Related]
2. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
[TBL] [Abstract][Full Text] [Related]
3. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
[TBL] [Abstract][Full Text] [Related]
5. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
6. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
8. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
Poryazova R; Benninger D; Waldvogel D; Bassetti CL
Eur Neurol; 2010; 63(3):129-35. PubMed ID: 20090346
[TBL] [Abstract][Full Text] [Related]
9. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia.
Liguori C; Romigi A; Mercuri NB; Nuccetelli M; Izzi F; Albanese M; Sancesario G; Martorana A; Sancesario GM; Bernardini S; Marciani MG; Placidi F
J Neurol; 2014 Sep; 261(9):1832-6. PubMed ID: 25119837
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
12. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
14. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin and human African trypanosomiasis.
Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
17. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
18. Case report: Excessive daytime sleepiness as a presenting manifestation of autoimmune glial fibrillary acidic protein astrocytopathy.
Tang M; Huang S; Guo W; Zhou J; Huang Z; Li W; Sun Q; Wang Z
Front Immunol; 2023; 14():1302514. PubMed ID: 38173730
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
20. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
